Sorry, this learning module is not available for mobile devices.
COPYRIGHT: Videos of live meetings of PRN in NYC are owned and published by Physicians' Research Network, Inc. Copyright © 2012. All rights reserved.
COLLABORATION STATEMENT: The AIDS Institute is proud of the ongoing collaboration between the Clinical Education Initiative (CEI) and Physicians Research Network (PRN). Founded in 1990, PRN has a well-established reputation for spotlighting the work of the most innovative and influential leaders in the HIV treatment, prevention and research fields through its monthly meetings in New York City. Since 2010, CEI has featured recordings of PRN's monthly events through the CEI website. The combined efforts of both educational institutions have enhanced the continuing educational resources available to New York State clinicians caring for people living with, or at risk for HIV.
Original Release Date: 3/27/2012
Review Date: 7/20/2012
Roy M. Gulick, MD, MPH
Rochelle Belfer Professor in Medicine, Chief, Division of Infectious Diseases, Weill Cornell Medicine
Weill Medical College of Cornell University, New York, NY
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
- Understand the evolving recommendations for when to start antiretroviral therapy (ART) for HIV disease.
- Identify optimal initial ART regimens.
- Know strategies for treatment-experienced patients.
- Learn about new antiretroviral agents for the treatment of HIV disease.
Roy M. Gulick, MD, MPH is the Rochelle Belfer Professor of Medicine and Chief of the Division of Infectious Diseases in the Department of Medicine at Weill Cornell Medicine/New York-Presbyterian Hospital. He is Principal Investigator of the NIH-funded Weill Cornell-New Jersey Medical School HIV Clinical Trials Unit and serves as the Co-Chair of the US DHHS Antiretroviral Treatment Guidelines Panel. He is an internationally-recognized leader in clinical research in HIV.
PRN Learning Modules